Alpha Teknova reports Q4 and FY2025 revenue growth, provides 2026 guidance of $42-44M

Alpha Teknova, Inc.

2025-FY EPS reported -$0.32 revenue$40,520,000

Full year 2025 total revenue $40.5M, up 7% from $37.7M in 2024.
Q4 2025 revenue $10.0M, up 8% from $9.3M in Q4 2024.
Clinical Solutions revenue up 47% in Q4 to $2.7M; 25% annual growth in Clinical Solutions customers.
Net loss improved to $17.3M in 2025 from $26.7M in 2024; Adjusted EBITDA improved to -$6.7M from -$14.5M.
Company expects 2026 revenue of $42-44M and free cash outflow less than $10M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.